Skip to Content
MDPIMDPI
Pharmacoepidemiology
Submit to PHARMACOEPIDEMIOLOGY
  • Tracked for
    Impact Factor
  • Indexed in
    Scopus
  • 22 days
    Time to First Decision

Pharmacoepidemiology, Volume 1, Issue 1

2022 June - 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Article
  • Open Access
2 Citations
6,632 Views
14 Pages
Download PDF

Multimedication in Family Doctor Practices: The German Evidence-Based Guidelines on Multimedication

  • Ingrid Schubert,
  • Joachim Fessler,
  • Sebastian Harder,
  • Truc Sophia Dinh,
  • Maria-Sophie Brueckle,
  • Christiane Muth and
  • on behalf of the EVITA Study Group
Pharmacoepidemiology2022, 1(1), 35-48;https://doi.org/10.3390/pharma1010005

13 May 2022

Patients with multimorbidity and multimedication require special attention from their treating physicians, as the risks of drug interactions and negative effects on adherence increase with the number of drugs. Most guidelines aim for the treatment of...

Full Article
  • Brief Report
  • Open Access
1 Citations
3,428 Views
7 Pages
Download PDF

Risk of Obstructive Sleep Apnea in Adults with Resistant Hypertension

  • Raj Desai,
  • Haesuk Park,
  • Joshua D. Brown and
  • Steven M. Smith
Pharmacoepidemiology2022, 1(1), 26-32;https://doi.org/10.3390/pharma1010003

12 May 2022

The risk of obstructive sleep apnea (OSA) in patients with resistant hypertension (RH) has not been well-quantified. We sought to evaluate the risk of OSA in patients with RH compared to those with treated but non-resistant hypertension (non-RH) usin...

Full Article
  • Article
  • Open Access
7 Citations
4,923 Views
14 Pages
Download PDF

Multimedication Guidelines: Assessment of the Size of the Target Group for Medication Review and Description of the Frequency of Their Potential Drug Safety Problems with Routine Data

  • Veronika Lappe,
  • Truc Sophia Dinh,
  • Sebastian Harder,
  • Maria-Sophie Brueckle,
  • Joachim Fessler,
  • Ursula Marschall,
  • Christiane Muth,
  • Ingrid Schubert and
  • on behalf of the EVITA Study Group
Pharmacoepidemiology2022, 1(1), 12-25;https://doi.org/10.3390/pharma1010002

15 April 2022

(1) Background: About 10 years ago, several guidelines for the better management of patients with polypharmacy were issued. A central issue is the definition of the target group. The primary aim of this study is therefore to assess the size of the ta...

Full Article
  • Article
  • Open Access
2 Citations
4,321 Views
10 Pages
Download PDF

Trend of Antihypertensive Medicine Use in the Baltic States between 2008 and 2018: A Retrospective Cross-National Comparison

  • Indre Treciokiene,
  • Nomeda Bratcikoviene,
  • Jolanta Gulbinovic,
  • Bjorn Wettermark and
  • Katja Taxis
Pharmacoepidemiology2022, 1(1), 1-11;https://doi.org/10.3390/pharma1010001

27 January 2022

High blood pressure is a major risk factor contributing to death and disability rates in the Baltic states. The aim of this study was to compare the utilization of antihypertensive medicines in Estonia, Latvia and Lithuania from 2008 to 2018. In this...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmacoepidemiology - ISSN 2813-0618
Imprint
Download Flyer